Clinical trial
Chemotherapy With Cordycepin Plus Pentostatin in Treating Patients With…
NCT00003005 · Boston Medical Center, Other · Completed
Key facts
| NCT number | NCT00003005 |
|---|---|
| Title | Chemotherapy With Cordycepin Plus Pentostatin in Treating Patients With Refractory Acute Lymphocytic or Chronic Myelogenous Leukemia |
| Official title | A Phase I Study of Cordycepin (NSC 63984) Plus 2'-Deoxycoformycin (NSC 218321) in Patients With Refractory TdT-Positive Leukemia |
| Lead sponsor | Boston Medical Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Leukemia |
| Intervention type | Drug |
| Interventions | Cordycepin, Deoxycoformycin |
| Enrollment | 14 |
| Start date | Dec 1, 1997 |
| Primary completion | Mar 1, 2001 |
| Completion | Mar 1, 2001 |
| First posted | Sep 3, 2004 |
| Last update posted | Jun 13, 2012 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: